物质信息
ID:349105
名称和标识
IUPAC传统名
(-)-malic acid; sunitinib
别名
SU 11248SU112248Sunitinib malateSU 011248N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioic acid (1:1) salt
IUPAC标准名
(2S)-2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
化合物性质
理化性质
溶解度
DMSO: >10 mg/mL
外观
powder
安全信息
GHS警示词
Danger
安全公开号
53-22-36/37
保存温度
room temp
德国WGK号
2
MSDS下载
危险公开号
61-2-48/25
GHS危险品标识
呼吸道过敏，类别1
生殖细胞突变，类别1A，1B，2
致癌性，类别1A，1B，2
生殖毒性，类别1A，1B，2
特定目标器官毒性 – 一次接触，类别1,2
特定目标器官毒性 – 反复接触，类别1,2
吸入危险，类别1
GHS警示性声明
P201-P308+P313
GHS危险声明
H360-H372
欧盟危险性物质标志
有毒 (T)产品相关信息
纯度
≥98% (HPLC)
Empirical Formula (Hill Notation)
C22H27FN4O2 · C4H6O5
描述信息
Biochem/physiol Actions
Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据